Drawing for MEDICLEANSE

USPTO serial 97106787

MEDICLEANSE

Reviewed by CopyMark Law Group

Status 654
Filing date
Status date
Registration date
—
Examiner
NGUYEN, CINDY EVANS
Law office
TMEG LAW OFFICE 106 - AWAITING RESPONSE DOCKET

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MEDICLEANSE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ira E. Silfin

Ira E. Silfin Mandelbaum Silfin LLC222 Bloomingdale RoadSuite120White Plains, NY 10605

Goods and services

ClassDescriptionStatusFirst use
005Medical cleansers for topical application to skin and wounds; pharmaceutical preparations for wounds; all of the foregoing for personal use, namely, application to human skin for treating, protecting and healing wounds and not for cosmetic useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 14, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Oct 19, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Apr 18, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Dec 18, 2024RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jan 16, 2024RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Aug 15, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Aug 15, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 15, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 15, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 13, 2023RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Nov 30, 2022GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Nov 30, 2022GNSLLETTER OF SUSPENSION E-MAILED—
Nov 30, 2022CNSLSUSPENSION LETTER WRITTEN—
Nov 18, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 17, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 17, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 29, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 29, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 29, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 12, 2022DOCKASSIGNED TO EXAMINER—
Nov 13, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 6, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance